Technology Supported High Intensity Training in Chronic Low Back Pain: the Techno-HIT Trial
Launched by HASSELT UNIVERSITY · Jul 3, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Techno-HIT Trial is studying a new exercise program called High Intensity Training (HIT) to help people with chronic low back pain (CLBP). This trial aims to see if HIT can reduce disability and improve overall health better than Moderate Intensity Training (MIT), which is commonly used. The researchers will also explore how technology, like smartphone apps, can support participants during their home workouts and if this added support makes a difference in their recovery.
To participate, individuals must be between 18 and 65 years old, speak Dutch, and have chronic low back pain that has lasted for at least 12 weeks. They should also have a smartphone that works with either iOS or Android. Participants can expect to engage in a personalized exercise program, receive support through technology, and help researchers understand the best ways to manage chronic low back pain. It's important to note that certain individuals, such as those who have had specific surgeries or other serious health conditions, may not be eligible for this trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • speak Dutch
- • be 18 to 65 years old
- • have nonspecific CLBP defined as chronic primary musculoskeletal pain (ICD-11: MG30.011) in the low back persisting for at least 12 weeks12, whereby fluctuations in pain can be present and pain can be alternated by remission phases. Furthermore, regarding the specification of 'severity', only participants with a profile consisting of a score of \>20% on the Modified Oswestry disability Index (i.e. 'moderate disability') will be included.
- • have and make use of a working iOS/Android smartphone
- Exclusion Criteria:
- • when they have had spinal fusion surgery
- • when they have a musculoskeletal and/or chronic disorder aside from CLBP that could affect the correct execution of the therapy program or evaluation of the outcomes
- • when they have severe comorbidities (e.g., paresis or sensory disturbances by neurological causes, diabetes mellitus, rheumatoid arthritis)
- • when they are pregnant
- • when they have ongoing compensation claims
- • when they are not able to attend regular therapy appointments
About Hasselt University
Hasselt University is a prestigious research institution located in Belgium, renowned for its commitment to advancing scientific knowledge and innovation. With a strong focus on interdisciplinary research, the university actively engages in clinical trials that aim to address pressing health challenges. Leveraging a robust network of collaborations with healthcare professionals, industry partners, and research organizations, Hasselt University strives to translate research findings into practical applications that benefit patient care and public health. The institution is dedicated to maintaining the highest ethical standards and regulatory compliance in all its clinical research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hasselt, , Belgium
Diepenbeek, Limburg, Belgium
Wilrijk, Antwerpen, Belgium
Wilrijk, Antwerpen, Belgium
Patients applied
Trial Officials
Annick Timmermans
Principal Investigator
Hasselt University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported